UNSPSC 85377309: Diagnosis of juvenile osteochondrosis of tibia and fibula

This classification denotes the group of activities that yields a diagnosis of Juvenile osteochondrosis of tibia and fibula. Juvenile osteochondrosis of tibia and fibula is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code M92. 5

UNSPSC 85377309 Diagnosis of juvenile osteochondrosis of tibia and fibula is a Commodity code that shows a marked disconnect between its nominal clinical diagnostic scope and the state and local procurement activity recently tagged under it. The three most recent opportunities posted under this code involve a diagnostic imaging PACS system implementation at a county medical center, special education contracted services across a school district, and a temporary health professional staffing qualification pool at a county health system — none of which concern juvenile bone disease diagnosis specifically. The code appears to capture health system procurement broadly rather than the narrow orthopedic diagnostic category its name suggests, reflecting either misclassification in source systems or a catch-all tagging practice by issuing bodies.

Activity under the code is sparse and geographically dispersed across California and Texas, with San Mateo County in California (San Mateo Medical Center, PACS system RFP due October 21, 2026), Birdville Independent School District in northeast Texas (special education services ITB due October 21, 2026, estimated cost $398,494.30 for the first contract year), and Santa Clara County, California (temporary health professional staffing RFQ with October 7, 2026 response date). The issuing bodies span a county health system, a school district, and another county health system — a thin and unrelated cross-section that does not suggest sustained procurement volume under this code tier for any specific product or service line. Prospective vendors should treat this code as low-activity and verify actual scope alignment with issuing bodies before bid pursuit, as the tagging practice does not reliably reflect the clinical specialty the code name describes.